These findings indicate a detrimental effect of activated EGFR in the pathogenesis of atherosclerosis, and that exacerbated EGFR phosphorylation contributes to the progression of atherosclerotic plaque formation, likely through increased inflammation and oxidative stress. The gene discussed is EGFR; the disease is atherosclerosis.